Site Members can sign up for company wide alerts
Lawsuit Overview
December5, 2022 - An amended complaint was filed. May 26, 2022 - An investor in shares of Spero Therapeutics, Inc. (NASDAQ: SPRO) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Spero Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between October 28, 2021...
You must register (for free) or login to view the entire case.